Arrhythmogenic right ventricular cardiomyopathy/dysplasia and naxos disease

Hellenic Journal of Cardiology

Volumn 45, Issue 6, 2004, Pages 370-378

  Protonotarios, Nikos I ^a   Tsatsopoulou, Adalena ^a  

^a Yannis Protonotarios Medical Centre   (Greece)

Author keywords

Arrhythmias; Cardiomyopathy; Cell junctions; Sudden death

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ELECTROCARDIOGRAM; GENE MUTATION; GENETIC ANALYSIS; HEART FAILURE; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; REVIEW; RISK ASSESSMENT;

EID: 30744443953     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Marcus FI, Fontaine GH, Guiraudon G, et al: Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982; 65: 384-398.
2. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N: Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988; 318: 129-133.
3. Protonotarios N, Tsatsopoulou A, Patsourakos P, et al: Cardiac abnormalities in familial palmoplantar keratosis. Br Heart J 1986; 56: 321-326.
4. Luderitz B: Naxos disease. J Interv Card Electrophysiol 2003; 9: 405-406.
5. Protonotarios N, Tsatsopoulou A, Scampardonis G: Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988; 319: 175.
6. Fontaine G, Protonotarios N, Tsatsopoulou A, Tsezana R, Fontaliran F, Frank R: Comparisons between Naxos disease and arrhythmogenic right ventricular dysplasia by electrocardiography and biopsy. Circulation 1994; 90: 3233.
7. Fontaine G, Protonotarios N, Fontaliran F, Tsatsopoulou A, Frank R: Pathology of arrhythmogenic right ventricular cardiomyopathies, dysplasia and Naxos disease: clinical, pathological and nosological classification. Cardiac arrhythmias, pacing and electrophysiology. Edited by PE Vardas. Kluwer Academic Publishers, 1998; pp. 97-104.
8. Richardson P, McKenna W, Bristow M, et al: Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93: 841-842.
9. Protonotarios N, Tsatsopoulou A, Scampardonis G: Arrhythmogenic cardiomyopathy with ectodermal dysplasia. Am Heart J 1988; 116: 1651.
10. Coonar AS, Protonotarios N, Tsatsopoulou A, et al: Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation 1998; 97: 2049-2058.
11. McKoy G, Protonotarios N, Crosby A, et al: Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000; 355: 2119-2124.
12. Schonberger J, Seidman CE: Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. Am J Hum Genet 2001; 69: 249-260.
13. Corrado D, Basso C, Thiene G, et al: Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997; 30: 1512-1520.
14. Cho Y, Park T, Yang DH, et al: Arrhythmogenic right ventricular cardiomyopathy and sudden death in young Koreans. Circ J; 67: 925-928.
15. Corrado D, Basso C, Schiavon M, Thiene G: Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 339: 364-369.
16. Maron BJ: Sudden death in young athletes. N Engl J Med 2003; 349: 1064-1075.
17. Protonotarios N, Tsatsopoulou A: Arrhythmogenic right ventricular cardiomyopathy. Clinical forms of the disease. Hellenic J Cardiol 1998; 39 (Suppl A): 78-80.
18. Protonotarios N, Tsatsopoulou A: The Naxos disease. In Nava A, Rossi L, Thiene G (ed): Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Elsevier Science BV, 1997, p. 454-462.
19. Protonotarios N, Tsatsopoulou A, Anastasakis A, et al: Genotype-phenotype assessment in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease) caused by a deletion in plakoglobin. J Am Coll Cardiol 2001; 38: 1477-1484.
20. Narin N, Akcakus M, Gunes T, et al: Arrhythmogenic right ventricular cardiomyopathy (Naxos disease): report of a Turkish boy. Pacing Clin Electrophysiol 2003; 26: 2326-2329.
21. Djabali K, Martinez-Mir A, Horev L, et al: Evidence for extensive locus heterogeneity in Naxos disease. J Invest Dermatol 2002; 118: 557-560.
22. Bukhari I, Juma'a N: Naxos disease in Saudi Arabia. J Eur Acad Dermatol Venereol 2004; 18: 614-616.
23. Protonotarios N, Tsatsopoulou A: Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Path 2004; 13: 185-194.
24. Norgett EE, Hatsell SJ, Carvajal-Huerta L, et al: Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Molec Genet 2000; 9: 2761-2766.
25. Alcalai R, Metzger S, Rosenheck S, Meiner V, Chajek-Shaul T: A recessive mutation in desmoplakin causes arrhythmogenic right ventricular dysplasia, skin disorder, and woolly hair. J Am Coll Cardiol 2003; 42: 319-327.
26. Rampazzo A, Nava A, Malacrida S, et al: Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2002; 71: 1200-1206.
27. Tiso N, Stephan DA, Nava A, et al: Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001; 10: 189-194.
28. Perriard JC, Hirschy A, Ehler E: Dilated cardiomyopathy: a disease of the intercalated disc? Trends Cardiovasc Med 2003; 13: 30-38.
29. Fontaine G, Fontaliran F, Hebert JL, et al: Arrhythmogenic right ventricular dysplasia. Ann Rev Med 1999; 50: 17-35.
30. Kaplan SR, Gard JJ, Protonotarios N, et al: Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm 2004; 1: 3-11.
31. Kanno S, Saffitz JE: The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc Pathol 2001; 10: 169-177.
32. Gemayel C, Pelliccia A, Thompson PD: Arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2001; 38: 1773-1781.
33. Nava A, Bauce B, Basso C, et al: Clinical profile and longterm follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2000; 36: 2226-2233.
34. Protonotarios N, Tsatsopoulou A, Gatzoulis K: Arrhythmogenic right ventricular cardiomyopathy caused by a deletion in plakoglobin (Naxos disease). Card Electrophysiol Rev 2002; 6: 72-80.
35. Protonotarios N, Tsatsopoulou A, Anastasakis A, Miliou A, Panagiotakos D, Toutouzas P: Evaluation of electrocardiographic and echocardiographic diagnostic criteria for ARVC in Naxos genotyped population. Eur Heart J 2002; 23(suppl): 357.
36. Nasir K, Bomma C, Tandri H, et al: Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation 2004; 110: 1527-1534.
37. Tsatsopoulou A, Protonotarios N, Anastasakis A, et al: Juvenile sudden death, arrhythmogenic right ventricular cardiomyopathy and Naxos disease. Paediatriki 1998; 61: 402-407.
38. Blomstrom-Lundqvist C, Sabel KG, Olsson SB: A longterm follow-up of 15 patients with arrhythmogenic right ventricular dysplasia. Br Heart J 1987; 58: 477-488.
39. McKenna WJ, Thiene G, Nava A, et al: Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group on Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994; 71: 215-218.
40. Bomma C, Rutberg J, Tandri H, et al: Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol 2004; 15: 300-306.
41. Sievers B, Addo M, Franken U, Trappe HJ: Right ventricular wall motion abnormalities found in healthy subjects by cardiovascular magnetic resonance imaging and characterized with a new segmental model. J Cardiovasc Magn Reson 2004; 6: 601-608.
42. Peters S, Peters H, Thierfelder L: Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-cardiomyopathy. Int J Cardiol 1999; 71: 243-250.
43. Wichter T, Paul M, Wollmann C, et al: Implantable cardioverter/ defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of longterm follow-up and complications in 60 patients. Circulation 2004; 109: 1503-1508.
44. Roguin A, Bomma CS, Nasir K, et al: Implantable cardioverter- defibrillators in patients with arrhythmogenic right ventricular dysplasia/ cardiomyopathy. J Am Coll Cardiol 2004; 43: 1843-1852.
45. Protonotarios N, Tsatsopoulou A, Anastasakis A, et al: Prognostic factors for arrhythmic events in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease). Eur Heart J 2002; 23(suppl): 6.
46. Basso C, Tsatsopoulou A, Thiene G, Anastasakis A, Valente M, Protonotarios N: "Petrified" right ventricle in long-standing Naxos arrhythmogenic right ventricular cardiomyopathy. Circulation 2001; 104: e132-e133.
47. Corrado D, Leoni L, Link MS, et al: Implantable cardioverter- defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Circulation 2003; 108: 3084-3091.
48. Gatzoulis K, Protonotarios N, Anastasakis A, et al: Implantable defibrillator therapy in Naxos disease. Pacing Clin Electrophysiol 2000; 23: 1176-1178.
49. Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G: Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992; 86: 29-37.
50. Basso C, Wichter T, Danieli GA, et al: Arrhythmogenic right ventricular cardiomyopathy: clinical registry and database, evaluation of therapies, pathology registry, DNA banking. Eur Heart J 2004; 25: 531-534.